Amarantus BioScience has released preliminary data from a blood test for multiple sclerosis (MS) called the MSPrecise diagnostic. The company believes that the test could lead to more accurate diagnoses of MS early in the disease’s progression.

MSPrecise is a DNA sequencing test designed to identify specific DNA mutations that are associated with the immune system, and more specifically, a type of immune system cell known as a B cell. The assay is intended to identify patients with relapsing-remitting multiple sclerosis (RRMS).

Read the story at Multiple Sclerosis News Today